City Holding Company (CHCO)
NASDAQ (NGS) NASDAQ (NGS) Primary 
City Holding (CHCO) Could Be a Great Choice
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does City Holding (CHCO) have what it takes?
Will City Holding (CHCO) Beat Estimates Again in Its Next Earnings Report?
City Holding (CHCO) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
SpaceX Drops 4% on Agreement to Testify in New York City AI Safety Probe; Intuitive Machines Sinks 6%, Virgin Galactic Holdings Slips
SpaceX (NASDAQ:SPCX | SPCX Price Prediction) stock trades at $156.69, down 4% early in the session, following the company's agreement to testify in a New York City artificial intelligence (AI) safety probe.
Delta Air Lines Adds Nonstop Salt Lake City-Flagstaff Service
DAL is set to launch twice-daily Salt Lake City-Flagstaff flights in 2027, expanding access to Sedona, the Grand Canyon and other leisure destinations.
NYC Lawmakers Grill AI Executives and Former Employees as City Weighs Guardrails
Former Anthropic researcher Jacob Coxon repeated his warnings at a hearing Monday.
Anthropic, OpenAI, Google and Meta execs set to testify at NYC Council hearing on AI risks
Senior leaders from Anthropic, OpenAI, Google and Meta are slated to testify under oath during a New York City Council hearing. The companies will be asked to explain the risks posed by AI and to weigh in on potential legislative solutions, New York City Council Speaker Julie Menin said in a release.
Former Anthropic researcher Coxon to testify at New York City AI hearing, Bloomberg News reports
Former Anthropic researcher Jacob Coxon will testify at a New York City hearing on artificial intelligence, Bloomberg News reported on Sunday, citing people familiar with the matter.
Yara International: Texas City Turns A European Gas Hostage Into A Spread Owner
Yara International is transitioning from a Europe-centric, high-cost ammonia producer to a more diversified, lower-cost, and lower-carbon operator. The acquisition of the Texas City ammonia plant and Sluiskil's carbon capture facility materially reduce YARIY's exposure to volatile European gas prices and carbon costs. Q2 results demonstrated strong margin resilience despite higher gas costs and operational outages, with ROIC more than doubling to 14.3% and EPS up 84%.
Are You Looking for a High-Growth Dividend Stock?
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does City Holding (CHCO) have what it takes?
City Therapeutics, RNAi Treatment Developer, Files For IPO
City Therapeutics is advancing next-generation RNAi therapeutics, with its lead program CITY-FXI targeting thrombosis and showing promising early Phase 1 trial results. CTY boasts significant big pharma collaborations, a strong investor syndicate, and experienced leadership, positioning it as a high-quality biopharma IPO candidate. IPO proceeds will fund CITY-FXI clinical trials, advance additional pipeline assets, and support platform development, with a typical 18-month cash runway targeted.
City Developments Limited (CDEVY) Shareholder/Analyst Call Transcript
City Developments Limited (CDEVY) Shareholder/Analyst Call Transcript
City Holding (CHCO) Upgraded to Buy: What Does It Mean for the Stock?
City Holding (CHCO) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
